Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/62367| Title: | Impact of Australia's 60-Day Dispensing Policy on Medicine Use: An Interrupted Time Series of the Stage 1 Roll-out. | Authors: | Janetzki J.;Pratt N.;Dalli L.;Cataldo-Miranda P.;Pearson S.-A.;Talic S.;Ellett L.K. | Monash Health Department(s): | Monash University - School of Clinical Sciences at Monash Health Cardiology (MonashHeart) Monash University - School of Public Health and Preventative Medicine |
Institution: | (Janetzki, Pratt, Ellett) Quality Use of Medicines and Pharmacy Research Centre, College of Health, Adelaide University, Adelaide, SA, Australia (Dalli) Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia (Dalli) Victorian Heart Institute, Monash University, Clayton, VIC, Australia (Cataldo-Miranda, Talic) PharmacoEpidemiology Research Group (PERG), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia (Pearson) Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW, Australia |
Issue Date: | 19-Oct-2026 | Copyright year: | 2026 | Publisher: | medRxiv | Place of publication: | United States | Publication information: | medRxiv. (no pagination), 2026. Date of Publication: 09 Sep 2026. | Journal: | medRxiv | Abstract: | Objective: To evaluate the real-world impact of Stage 1 of Australia's 60-day dispensing policy on medicine utilisation and contextualise changes in dispensing with medicine shortages. Method(s): We conducted an interrupted time series analysis of aggregated national monthly dispensing data from the Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical Benefits Scheme for the 247 medicines included in Stage 1 of the 60-day dispensing policy. Data from January 2020 to October 2025 were analysed, with September 2023 defined as policy implementation. Linear regression assessed changes in monthly dispensing trends before and after implementation, accounting for autocorrelation and seasonal variation. A relative change of at least +/-5% in the post-intervention dispensing slope compared with the pre-intervention slope was prespecified as a potentially clinically meaningful change. Therapeutic Goods Administration shortage reports were used to contextualise observed changes. Result(s): Of 247 medicines, 131 (53%) had increasing and 116 (47%) had decreasing post-intervention dispensing trends; of which 86 (66%) and 71 (61%), were statistically significant, respectively. However, only 8 medicines (3%) demonstrated at least +/-5% relative change in dispensing slope, six of which had reported shortages. Medicine-specific changes coincided with shortages, product deletions and therapeutic substitution, complicated attribution of changes to the 60-day dispensing policy. Conclusion(s): Stage 1 of Australia's 60-day dispensing policy was not associated with widespread changes in dispensing for most included medicines. Limited changes were plausibly influenced by concurrent shortages and other supply-related events. These findings provide reassurance that extended dispensing did not result in major increases in medicine utilisation at the population level, although continued monitoring is warranted as policy uptake expands.Copyright © 2026, Posted by openRxiv | DOI: | http://monash.idm.oclc.org/login?url=10.64898/2026.09.09.26362679 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/62367 | Type: | Preprint | Subjects: | Australia autocorrelation drug shortage drug substitution drug use drug utilization linear regression analysis pharmacoeconomics reassurance seasonal variation special situation for pharmacovigilance time series analysis |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
